Skip to main content
Text "Experts in Life Sciences Communications" on a blurred background

MC Services is an international Corporate Communications and Investor Relations firm providing Life Sciences companies high-level consultancy, targeted services and support throughout Europe and beyond

Our Services

Corporate Communications pictogram

Corporate Communications

Designing, implementing and effectively operating international Corporate Communications programs is part of our core expertise.

Investor Relations pictogram

Investor Relations

Our trained senior Investor Relations specialists provide a unique opportunity to have immediate access to the necessary tools, skills and networks you need in Europe, the UK and the US.

Roadshows & Transactions pictogram

Roadshows & Transactions

We target the appropriate audience for the unique investment proposition of your Company and help raise capital through IPOs, secondary offerings or other equity financings.
Product & Science PR pictogram

Product & Science PR

Right from its scientific beginnings, and all the way through regulatory approval and market launch we support the strategic positioning and marketing of your product – and the science behind it – to the relevant stakeholders.

SELECTED CLIENTS – PAST AND PRESENT

Client News

3rd February 2026
Newron Notes Publication Highlighting Clinically Meaningful Benefits of Evenamide as an Adjunctive Treatment in Schizophrenia
29th January 2026
InflaRx Announces Participation in February Investor Conferences
22nd January 2026
Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development U.S.

MC Services is Media Partner for LSI USA ’26 Medtech & Healthtech Summit

MC Services is proud to serve as media partner for LSI USA ’26, a leading event for medtech and healthtech that unites innovators, investors, and strategic partners shaping the future of medical technology. The summit will take place March 16-20, 2026, in Dana Point, California, bringing together the brightest minds in the industry to drive investment, partnerships, and commercialization of groundbreaking medtech and healthtech innovations.

MCS on LinkedIn